TBIO Stock Price History and Quote Analysis Insights for Investors

NASDAQ : TBIO

Telesis Bio, Inc.

$0.37

-0.0004-0.11%

At Close 4:00 PM

$2.85

2.48+670.27%

After-Market 07:59 PM

65.44

ESG ScoreESG Rating

profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Price Today

Telesis Bio, Inc. (TBIO) stock declined over -0.11%, trading at $0.37 on NASDAQ, down from the previous close of $0.37. The stock opened at $0.35, fluctuating between $0.35 and $0.37 in the recent session.

Stock Snapshot

0.3704

Prev. Close

0.35

Open

657.06K

Market Cap

1.78M

Number of Shares

0.3461

Day Low

0.3704

Day High

-0.01

P/E Ratio

68.05%

Free Float in %

-30.42

EPS (TTM)

0.98

Book Value

-1.22

Cash Flow per Share

1.61K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 13, 2024	0.40	0.40	0.40	0.40	527
Dec 12, 2024	0.50	0.68	0.35	0.37	3.53K
Dec 11, 2024	0.69	0.69	0.46	0.46	910
Dec 10, 2024	0.55	0.60	0.55	0.58	1.56K
Dec 09, 2024	0.51	0.56	0.51	0.56	6.27K
Dec 06, 2024	0.60	0.65	0.57	0.57	4.22K
Dec 05, 2024	0.57	0.63	0.57	0.63	5.1K
Dec 04, 2024	0.63	0.70	0.57	0.57	29.8K
Dec 03, 2024	0.70	0.73	0.70	0.73	2.03K
Dec 02, 2024	0.60	0.91	0.60	0.75	3.76K
Nov 29, 2024	0.60	0.60	0.60	0.60	909
Nov 27, 2024	0.64	0.71	0.64	0.64	1.53K
Nov 26, 2024	0.66	0.66	0.61	0.61	1.1K
Nov 25, 2024	0.85	0.87	0.76	0.87	3.23K
Nov 22, 2024	0.90	0.92	0.90	0.91	11.12K
Nov 21, 2024	0.90	0.90	0.90	0.90	1K
Nov 20, 2024	0.95	0.95	0.90	0.90	4.1K
Nov 19, 2024	0.95	0.95	0.95	0.95	200
Nov 18, 2024	0.91	0.95	0.91	0.95	1.51K
Nov 15, 2024	0.92	0.93	0.91	0.93	2.5K

Contact Details

Lexington, MASSACHUSETTS 92121-2993

United States

Website: https://codexdna.comContact: 161 794 57361

About Company

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Frequently Asked Questions

What is the current Telesis Bio, Inc. (TBIO) stock price?

Telesis Bio, Inc. (NASDAQ: TBIO) stock price is $0.37 in the last trading session. During the trading session, TBIO stock reached the peak price of $0.37 while $0.35 was the lowest point it dropped to. The percentage change in TBIO stock occurred in the recent session was -0.11% while the dollar amount for the price change in TBIO stock was -$0.00.

TBIO's industry and sector of operation?

The NASDAQ listed TBIO is part of Medical - Devices industry that operates in the broader Healthcare sector. Telesis Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TBIO?

Mr. Laurence Warden
Senior Vice President of Engineering & Instrumentation
Richard Lepke
Director of Investor Relations
Mr. Brent M. Hunter
Executive Officer
Mr. Eric Esser
Pres & Chief Operating Officer
Dr. Todd R. Nelson MBA, Ph.D.
Chief Executive Officer & Director
Mr. Daniel G. Gibson Ph.D.
Chief Technology Officer
Mr. Robert H. Cutler
Chief Legal Officer
Ms. Jen Carroll
Vice President of Investor Relations
Ms. Laura B. Puga M.B.A.
Vice President of People & Culture
Mr. Decky Goodrich M.B.A.
Senior Vice President of Commercial Operations

How TBIO did perform over past 52-week?

TBIO's closing price is 6.91% higher than its 52-week low of $0.35 where as its distance from 52-week high of $15.46 is -97.61%.

How many employees does TBIO have?

Number of TBIO employees currently stands at 137.

Link for TBIO official website?

Official Website of TBIO is: https://codexdna.com

How do I contact TBIO?

TBIO could be contacted at phone 161 794 57361 and can also be accessed through its website. TBIO operates from 29 Hartwell Ave, Lexington, MASSACHUSETTS 92121-2993, United States.

How many shares of TBIO are traded daily?

TBIO stock volume for the day was 1.61K shares. The average number of TBIO shares traded daily for last 3 months was 1.43M.

What is the market cap of TBIO currently?

The market value of TBIO currently stands at $657.06K with its latest stock price at $0.37 and 1.78M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	137
Beta	1.76
Sales or Revenue	$27.51M
5Y Sales Change%	28.208%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices